Earningsreport

Q2/2024 10/31/2023 EPS -0.150 ZacksConsensus -0.170 ActVsEst 0.020 - Beat

Champions Oncology, Inc.  (CSBR) 
NASDAQ:AMEX Investor Relations: championsoncology.com/investors